Applications published 11 April 2007
Compsn for delivery of an active agent
Quadrant Drug Delivery 1771153*
Galenic applications of self-emulsifying mixtures of lipidic excipients
Aventis Pharma 1771154*
Method and compsn for treating rhinitis
Biolipox 1771155*
Sterol enriched mixed lamellarity amphotericin intercalating liposomes in saline and the process for their preparation
Verma, Jitendra; Verma, Lily; Tripathi, Krishan 1771156*
Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form
Roehm 1771157*
Tablet for pulsed delivery
Advancis Pharmaceutical; Cao, Bruce; Wassink, Sandra; Treacy, Donald; Bumside, Beth; Rowlings, Colin; Bonck, John 1771158*
Sustained-release preparations containing topiramate and the producing method thereof
Amorepacific Corp 1771159*
Alcohol resistant dosage forms
Euroceltique 1771160*
Taste masking formulation in a dissolution-retarded form and/or cyclodextrinin a dissolution-enhanced form
Pfizer 1771161*
Capsaicin inhibitors for treating obesity and related disorders
Novo Nordisk 1771162*
RXR antagonist treatment against multiple sclerosis
Bollag, Werner 1771163*
Multitherapy against cancer
Schwartz, Laurent; Israel, Maurice 1771164*
Hydroalcoholic depigmentation gel comprising mequinol and adapalene
Galderma Research & Development 1771165*
RXR antagonists in the treatment of inflammatory diseases
Bollag, Werner 1771166*
Histone deacetylase inhibitors
Merck 1771167*
Compsns capable of inhibiting reactive oxygen and carbonyl species
Baxter International; Baxter Healthcare 1771168*
Methods for treating hepatitis C
PTC Therapeutics; Hwang, Peter; Takasugi, James; Ren, Hongyu; Wilde, Richard; Turpoff, Anthony; Arefolov, Alexander; Karp, Gary; Chen, Guangming; Campbell, Jeffrey 1771169*
Ophthalmic compsns for treating ocular hypertension
Merck 1771170*
Use of ALK5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in mammal
Schering-Plough 1771171*
Treatment of tumours
AQ+ 1771172*
Treatment of burns
AQ+ 1771173*
Method for treating abnormal cell growth
Pfizer 1771174*
Phthalazine derivatives as PARP inhibitors
Janssen Pharmaceutica 1771175*
Methods and compsns
SmithKline Beecham 1771176*
Processes and intermedaites useful for preparing fused heterocyclic kinase inhibitors
Bristol-Myers Squibb 1771177*
Use of K-25A and kinase inhibitors for the prevention or treatment of HMGB1-associated pathologies
Creabilis Therapeutics; Bio3Research 1771178*
Compsns comprising 5-alpha reductase inhibitors, and SERMs and methods of use
GTX 1771179*
Compsn in the form of a spray comprising a combination of clo-betasol propionate and calcitrol, an alcohol phase and an oily phase
Galderma 1771180*
Phosphole derivatives complexed with metals, and pharmaceutical uses thereof
Centre National de la Recherche Scientifique 1771181*
Anti-parasitic uses of borinic acid complexes
Anacor Pharmaceuticals 1771182*
Antimicrobial complexes and uses thereof
The Trustees of the University of Pennsylvania 1771183*
Calcium phosphate cements and methods for using the same
Skeletal Kinetics 1771184*
Emu oil and fruit compsn
Pleva, Raymond 1771185*
Herbal compsn
Lavender Hill Projects 1771186*
Morinda citrifolia leaf extract compsns and methods of obtaining the same
Morinda 1771187*
Methods and compsns for the treatment of obesity, insulin related diseases and hypercholesterolemia
Michigan State University 1771188*
Methods of treating type 1 diabetes by blocking VEGF-mediated activity
Regeneron Pharmaceuticals 1771189*
Method of producing fully carbamylated erythropoietin
The Kenneth S Warren Institute 1771190*
Preparation of aspartate and vitamin B12 or biotin for regulating ketone bodies
NV Nutricia 1771191*
Use of aspartate for regulating glucose levels in blood
NV Nutrica 1771192*
GUS3 neuropeptides for regulating hypothalamic function
Rheoscience 1771193*
Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
Biodevelops Pharma Entwicklung 1771194*
Pharmaceutical compsn comprising botulinium toxin for treating knee joint pain by saphenous nerve entrapment
Ipsen 1771195*
CCR ligands for stem cell homing
The Cleveland Clinic Foundation 1771196*
Pegylated interferon alpha-1B
Egen Corp 1771197*
Interferon-alpha polypeptides and conjugates
Maxygen 1771198*
Long-acting colloidal insulin formulation and preparation thereof
Flamel Technologies 1771199*
Physiologically-active compsn based on collagen
Gargill 1771200*
Compsns and methods for treating or preventing oxalate-related disease
OxThera 1771202*
Inhibition of NF-KB
Cleveland Clinic Foundation 1771203*
Compsns and methods for modulation of ROR Gamma T
New York University 1771204*
Novel antigen-binding polypeptides and their uses
Ambrax 1771205*
Lipids, lipid complexes and use thereof
atugen 1771206*
Methods of treating cancer using agents that inhibit WNT16 signalling
The Regents of the University of California 1771207*
Use of thioflavin radiolabelled derivatives in amyloid imaging for assessing anti-amyloid therapies
University of Pittsburgh 1771208*
Stabilised and lyophilised radiopharmaceutical agents
Anazaohealth 1771209*
Method for preparing 4-[2-(dimethylamino)ethoxy]benzylamine as itopride hydrochloride salt mediate
Il Yang Pharm 1771408*
N-acylated derivatives of dicarboxylic acids with amino acids and vegetable protein hydrosylates and their use in cosmetics and pharmaceuticals
Maycos Italiana di Comini Miro 1771409*
Spirolactams and their synthesis
Laboratoires Del Dr Esteve 1771410*
Crystalline forms of [R-(R*)]-2-(4-fluorophenyl)-bet a,gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
Warner-Lambert 1771412*
Indole, benzofuran and benzothiphene derivatives as selective androgen receptor receptor modulators (SARMS)
Janssen Pharmaceutica 1771413*
Amorphous tegaserod maleate
Teva Pharmaceutical Industries 1771414*
2-(1H-indolylsulphanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence
H Lundbeck 1771415*
A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof
USV 1771416*
Substituted 3-phenylpiperidine derivatives
Gruenenthal 1771417*
Large conductance calcium-activated K channel opener
Tanabe Seiyaku 1771418*
Preparation of novel substituted haloarene compounds
Pfizer Products 1771419*
Novel 2,6-diaminopyridine-3-one derivatives
F Hoffmann-La Roche 1771420*
N-hydroxyamide derivatives and use thereof
Applied Research Systems 1771421*
Quinazolinone derivatives as PARP inhibitors
Janssen Pharmaceutica 1771422*
Novel 2,4-diaminothiazol-5-one derivatives
F Hoffmann-La Roche 1771424*
2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
Sanofi-Aventis 1771425*
Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatatse 1B (PTP1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes
Sanofi-Aventis Deutschland 1771426*
Prostaglandin analogues
Allergan 1771427*
Guanidine derivatives and therapeutic uses thereof
Merck Patent 1771428*
Bew benzoyl urea derivatives
Richter Gedeon Vegyeszeti Gyar 1771429*
Preparation of alpha-hydroxy and alpha-amino ketones
Ciba Speciality Chemicals Holding 1771430*
Intermediates for the preparation of halichondrin B
Eisai 1771431*
Non-imidazole heterocyclic compounds as histamine H3 receptor modulators
Janssen Pharmaceutica 1771432*
Method for the isolation of alpha-mangostin
Boehringer Ingelheim Pharma 1771433*
Method for the preparation of 3-amino-5-(hydroxymethy)cyclopentane-1,2-diol derivatives
Lonza 1771434*
Modulators of central nervous system neurotransmitters
Human biomolecular Research Institute 1771435*
Kynurenic acid amide derivatives as NR2B receptor antagonists
Richter Gedeon Vegy Szeti 1771436*
New heterocyclic carboxylic acid amide derivatives
Richter Gedeon Vegyeszeti Gyar 1771437*